Cost‐Effectiveness Analysis of HLA–B5801 Genotyping in the Treatment of Gout Patients With Chronic Renal Insufficiency in Korea

Publisher： John Wiley & Sons Inc

E-ISSN： 2151-4658|67|2|280-287

ISSN： 2151-464x

Source： ARTHRITIS CARE AND RESEARCH, Vol.67, Iss.2, 2015-02, pp. : 280-287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of treatment‐naïve chronic hepatitis C genotype 1 patients: a cost‐effectiveness analysis of treatment options

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 2, 2015-02 ,pp. : 175-183

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost‐effectiveness of sofosbuvir for the treatment of chronic hepatitis C‐infected patients

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 11, 2015-11 ,pp. : 882-889

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost‐effectiveness of sofosbuvir for the treatment of chronic hepatitis C‐infected patients

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 1352-0504, Iss. 11, 2015-11 ,pp. : 882-889

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost‐effectiveness of sofosbuvir in the treatment of patients with hepatitis C

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 4, 2015-04 ,pp. : 376-383

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost-effectiveness of peginterferon alfa-2b in combination with ribavirin as initial treatment for chronic hepatitis C in Sweden

By Bernfort Lars   Sennfält Karin   Reichard Olle  

Scandinavian Journal of Infectious Diseases, Vol. 38, Iss. 6-7, 2006-07 ,pp. : 497-505

Informa Healthcare

Access to resources Recommend Favorite